This marks the first step in establishing a combined pilot and GMP manufacturing function, including Quality Assurance and Control, describes the company.

“Outi’s leadership will be central as we prepare to scale up our development projects and enable clinical trial supply in the future,” states DelSiTech.

Prior to her promotion, Outi had served as Director, Head of Manufacturing at DelSiTech since 2022.